Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adrenoleukodystrophy: a scoring method for brain MR observations

D J Loes1, S Hite, H Moser

  • 1University of Minnesota Hospital and Clinic, Department of Radiology, Minneapolis 55455.

AJNR. American Journal of Neuroradiology
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CSF and plasma neuro-biomarker dynamics after gene therapy for cerebral adrenoleukodystrophy.

Molecular therapy. Advances·2026
Same author

Age-specific vulnerabilities in paediatric dental emergencies before, during, and after COVID-19 lockdown: a retrospective comparative analysis with emphasis on early childhood (0-3 years).

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2025
Same author

Increasing precision in the measurement of change in pediatric neurodegenerative disease.

Molecular genetics and metabolism·2022
Same author

Early psychological interventions for prevention and treatment of post-traumatic stress disorder (PTSD) and post-traumatic stress symptoms in post-partum women: A systematic review and meta-analysis.

PloS one·2021
Same author

Response to: Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome.

Molecular genetics and metabolism reports·2020
Same author

The American Academy of Pediatrics Workforce Survey for the Section on Urology 2015.

Journal of pediatric urology·2017
Same journal

Neuroradiology Leads NIH Funding Among Clinician Diagnostic Radiologists: A 14-Year National Analysis.

AJNR. American journal of neuroradiology·2026
Same journal

Neutral Cervical Spine MRI is Not Enough: The Critical Role of Flexion Imaging in Hirayama disease in Pediatric Patients.

AJNR. American journal of neuroradiology·2026
Same journal

CT Evaluation of Osseous Trauma at the Craniocervical Junction: A Pattern-Based Overview.

AJNR. American journal of neuroradiology·2026
Same journal

Comprehensive Structural MRI Phenotyping in <i>Oligophrenin 1-</i>Related Disorder Reveals Characteristic Brain Malformations.

AJNR. American journal of neuroradiology·2026
Same journal

ASNR-ESNR White Paper on Sustainability in Neuroradiology.

AJNR. American journal of neuroradiology·2026
Same journal

Intracranial Atherosclerotic Disease Distribution Across Circle of Willis Segments: Insights from CREST-H.

AJNR. American journal of neuroradiology·2026
See all related articles

A new scoring method for brain magnetic resonance imaging (MRI) observations in X-linked adrenoleukodystrophy (ALD) has been developed. This tool aids in assessing disease severity and progression in pediatric patients.

Area of Science:

  • Neurology
  • Radiology
  • Genetics

Background:

  • X-linked adrenoleukodystrophy (X-ALD) is a rare genetic disorder affecting the adrenal glands and white matter of the brain.
  • Early diagnosis and monitoring of X-ALD are crucial for managing disease progression and therapeutic interventions.
  • Standardized assessment tools are needed to evaluate the neurological impact of X-ALD.

Purpose of the Study:

  • To develop and validate a quantitative scoring method for brain magnetic resonance imaging (MRI) findings in pediatric patients with X-linked adrenoleukodystrophy.
  • To establish a reliable measure for assessing the extent and pattern of demyelination and atrophy in X-ALD.
  • To provide a tool for monitoring disease progression and evaluating treatment efficacy.

Main Methods:

Related Experiment Videos

  • Review of 175 brain MRI scans from 83 male subjects under 20 years old with confirmed X-ALD.
  • Development of a severity score (0-34) based on lesion location, extent, and presence of atrophy.
  • Analysis of imaging patterns, including posterior and anterior predominant disease, and assessment of disease progression over time.

    • Main Results:

    • Fifty-five of 83 patients exhibited MRI findings characteristic of X-ALD.
    • Two primary patterns were identified: posterior (80% of cases, mean score 9) and anterior (15% of cases, mean score 10).
    • Serial imaging in 34 patients revealed progressive disease in 52%, with varying degrees of stabilization and improvement observed over a mean follow-up of 23 months.

    Conclusions:

    • The developed MRI severity scoring method provides a quantitative assessment for X-ALD brain involvement.
    • This scoring system can be integrated with clinical data to better understand X-ALD natural history.
    • The method holds potential for monitoring therapeutic responses in developing X-ALD treatments.